Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
For patients with challenging cancers like lymphoma and sarcoma, subtle genetic differences can dramatically change the way doctors diagnose and treat their disease. There are more than 70 recognized ...
Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a while. He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that ...
IRVINE, Calif., March 18, 2026 /PRNewswire/ -- Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider ...
Scientists have recently been learning more about the importance of small bits of circular genetic material known as extrachromosomal DNA (ecDNA). These little circles of DNA can hitch a ride with ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a ...
As genetics and genomics become more central in healthcare, demand is growing for professionals who can interpret increasingly complex genetic information, help translate scientific advances into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results